|
|
|
Stem Cell Related Patent Number US6365796
| Title: | Transgenic UCP2 knockout mouse and use thereof | | Inventors: | Lowell, Bradford B.; Southborough, MA | | Summary: | This invention describes a method for providing a transgenic mouse that lacks the UCP2 gene which encodes the UCP2 protein, thereby yielding a mouse that releases an increased level of insulin in response to glucose stimulation. The mouse thus provides a source of cells that are useful in the identification and evaluation of the signaling ability of agents, such as in beta-cells, and which therefore constitutes a method of treating diseases and conditions associated with UCP2 function. | | Abstract: | The present invention provides a transgenic non-human mammal which lacks a functional UCP2 gene. The UCP-2 deficient transgenic knockout mammal described herein provides a source of cells and animals useful to practice methods for the identification and/or evaluation of agents for their ability to affect signaling in cells, such as pancreatic .beta.-cells, in which ATP serves a regulatory function. Further aspect of the invention provide a method for the identification of agents (e.g., therapeutic agents) which inhibit UCP2 activity; a method for the identification of agents which mimic UCP2 activity and a method of treating diseases or conditions associated with UCP2 function (e.g., negative regulation or uncoupling activity). | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6365796 | | Application Number: | US2000000505298 | | Date Filed: | 16/02/2000 | | Date Published: | 02/04/2002 | | Assignee: | Beth Israel Deaconess Medical Center, Boston, MA, USA |
|
|
